Drug Trial Radar · NCT06680232
Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B
Last checked: Nov 20, 2026Latest source record: Aug 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
45
Planned (sponsor's estimate)
Start
Nov 14, 2024
Primary completion
Dec 2026
Study completion Jun 2027
Sponsor
- Lead sponsor
- Precision BioSciences, Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 8, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 1, open-label, dose escalation and dose expansion study to evaluate the safety, tolerability, PK, and antiviral activity of PBGENE-HBV in adult participants with chronic hepatitis B.
Conditions
- HEPATITIS B CHRONIC
Interventions
PBGENE-HBVBiological
PBGENE-HBV is an in vivo gene editing intervention based on a novel proprietary ARCUS® platform designed to potentially cure chronic hepatitis B virus (HBV) by eliminating cccDNA, the key source of replicating hepatitis B virus, while also inactivating integrated HBV DNA in hepatocytes.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety to Assess Treatment-emergent Adverse Events (TEAEs)Time frame: 4 weeks after final dose
Locations
7 sites in 6 countries. Site status is shown where the registry gives one.
Massachusetts General Hospital/Harvard University
Boston, Massachusetts · Recruiting
Hospital Beaujon
Clichy, France, France · Recruiting
Queen Mary Hospital, The University of Hong Kong
Hong Kong, Hong Kong, Hong Kong · Recruiting
ICS ARENSIA Exploratory Medicine SRL
Chisinau, Moldova · Recruiting
New Zealand Clinical Research
Auckland, New Zealand · Recruiting
ARENSIA Exploratory Medicine
Bucharest, Romania, Romania · Recruiting
Arensia Exploratory Medicine in collaboration with County Clinical Emergency Hospital
Cluj-Napoca, Romania, Romania · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.